Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
Saved in:
| Title: | Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. |
|---|---|
| Authors: | Kim MJ (AUTHOR), Frankel AH (AUTHOR), Donaldson M (AUTHOR), Darch SJ (AUTHOR), Pusey CD (AUTHOR), Hill PD (AUTHOR), Mayr M (AUTHOR), Tam FW (AUTHOR), Kim, Min Jeong1 (AUTHOR), Frankel, Andrew H (AUTHOR), Donaldson, Mandy (AUTHOR), Darch, Sarah J (AUTHOR), Pusey, Charles D (AUTHOR), Hill, Peter D (AUTHOR), Mayr, Michael (AUTHOR), Tam, Frederick W K (AUTHOR) |
| Source: | Kidney International. Oct2011, Vol. 80 Issue 8, p851-860. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00852538 |
|---|---|
| DOI: | 10.1038/ki.2011.224 |
